Seelos Therapeutics, Inc. Share Price
Stocks
SEELQ
US81577F4063
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
19:06:37 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
| Market Cap | 101K 92.24K 84.99K 77.31K 145K 9.38M 152K 1.03M 411K 5.12M 380K 372K 16.08M | P/E 2022 |
-0.98x | P/E 2023 | -0.18x |
|---|---|---|---|---|---|
| Enterprise Value | 11.33M 10.32M 9.51M 8.65M 16.23M 1.05B 17.06M 116M 46.01M 573M 42.52M 41.63M 1.8B | EV / Sales 2022 |
-
| EV / Sales 2023 | 11,278,456x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 698.88 | |
| 5 years | 0 | 8,121.61 | |
| 10 years | 0 | 28,761.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 31/12/2018 |
Anthony Marciano
IRC | Investor Relations Contact | - | 31/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/02/24 | Free | Chief Financial Officer | 417 | 0.0043% | ||
| 12/01/24 | Free | Chief Financial Officer | 24,537 | 0.2505% | ||
| 12/01/24 | Free | Chief Executive Officer | 70,383 | 0.7186% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1 | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -1.24% | -1.09% | +33.67% | +175.26% | 40B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 2.2 2.01 1.85 1.68 3.16 204 3.32 22.5 8.94 111.42 8.27 8.09 349.69 |
| Net income | -73.53M -66.97M -61.71M -56.14M -105M -6.81B -111M -751M -299M -3.72B -276M -270M -11.67B | -37.88M -34.5M -31.79M -28.92M -54.25M -3.51B -57.02M -387M -154M -1.92B -142M -139M -6.01B |
| Net Debt | 4.59M 4.18M 3.85M 3.5M 6.57M 425M 6.91M 46.87M 18.63M 232M 17.22M 16.85M 728M | 11.23M 10.23M 9.43M 8.57M 16.09M 1.04B 16.91M 115M 45.6M 568M 42.14M 41.25M 1.78B |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | US$0.000000 | - | 4 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
Select your edition
All financial news and data tailored to specific country editions
















